USPTO serial 79168375
LYOPAN
Reviewed by CopyMark Law Group
Reg. 4872521Status 404
- Filing date
- Status date
- Registration date
- Dec 22, 2015
- Examiner
- FLETCHER, TRACY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LYOPAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CH-6362 Stansstad, CH
CH-6362 Stansstad, CH
CH-6362 Stansstad, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Alumit
John Alumit ALUMIT IP135 S. Jackson Street, Suite 200Glendale, CA 91205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; photographic chemicals; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; soil fertilizers; fire extinguishing compositions; tempering preparations; soldering chemicals; tempering chemicals for use in soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives for use in industry; descaling preparations and descaling preparations in tablet form for industrial purposes | SECTION 71 - CANCELLED | — |
| 003 | Dental bleaching gels, Tooth bleaching preparations, Laundry bleach, blueing, detergent, pre-soak, sizing, soap and starch; general purpose cleaning, polishing, degreasing and abrasive liquids and powders; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices; descaling agents and descaling agents in tablet form for household use; all-purpose cleaning preparations | SECTION 71 - CANCELLED | — |
| 005 | Almond oils for pharmaceutical purposes; Antibacterial pharmaceuticals; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of nutritional supplements and of pharmaceutical preparations; Homeopathic pharmaceuticals for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for skin care; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the treatment of joint disease; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, anti-infectives; Amino acids for medical or veterinary purposes; Anti-infective products for veterinary use; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Biochemical preparations, namely, reagents for medical and veterinary diagnostic purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Veterinary preparations, namely, pain relief medication; Veterinary preparations for treatment of intestinal bacteria; Veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in a variety of animal; Veterinary preparations, namely, antioxidants; veterinary vaccines; health care preparations, namely, dietary supplements; Dietetic foods adapted for medical use, namely, bread, cookies and crackers; Diet capsules, Diet pills, Food for medically restricted diets, namely, pasta, crackers and candy adapted for medical use; food for babies; medical plasters; medical dressings; material for dental fillings and dental impressions; all-purpose disinfectants; Gastrointestinal cleaning agents; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic candy; preparations for destroying vermin; fungicides; herbicides; nutritional supplements; pharmaceutical effervescent tablets for treating upset stomach and stomach disease; medicine delivery agents in the form of soft-gelatin capsules for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of powders for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of tablets for the controlled release of active ingredients for a wide range of pharmaceutical products | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pantec AG
- Other trademarks owned by Pantec AG
- Other trademarks owned by Pantec AG
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named LYOPAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 8, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 9, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 20, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 20, 2023 | INPC | INVALIDATION PROCESSED | — |
| Mar 8, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 8, 2022 | C71T | CANCELLED SECTION 71 | — |
| Dec 22, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 11, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 11, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 22, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 22, 2016 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 12, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Dec 22, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 6, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 6, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 16, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 16, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 16, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 1, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 28, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 28, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 28, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 27, 2015 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Aug 27, 2015 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Aug 27, 2015 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Aug 27, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 5, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 5, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 5, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 5, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 28, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 19, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 13, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 13, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 12, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 11, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |